- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1113EUR$1,250USD£971GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1113EUR$1,250USD£971GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1113EUR$1,250USD£971GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1113EUR$1,250USD£971GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1113EUR$1,250USD£971GBP
- Report
- June 2024
- 200 Pages
Global
From €7080EUR$7,950USD£6,173GBP
- Report
- January 2024
- 189 Pages
Global
From €6679EUR$7,500USD£5,824GBP
- Report
- March 2024
- 200 Pages
Global
From €3696EUR$4,150USD£3,223GBP
- Report
- May 2025
- 70 Pages
Japan
From €4230EUR$4,750USD£3,689GBP
- Report
- February 2024
- 70 Pages
United States
From €4230EUR$4,750USD£3,689GBP
- Report
- February 2024
- 70 Pages
China
From €4230EUR$4,750USD£3,689GBP
- Report
- February 2024
- 70 Pages
Thailand
From €4230EUR$4,750USD£3,689GBP
- Report
- February 2024
- 70 Pages
Philippines
From €4230EUR$4,750USD£3,689GBP
- Report
- February 2024
- 70 Pages
Oman
From €4230EUR$4,750USD£3,689GBP
- Report
- February 2024
- 70 Pages
Iran
From €4230EUR$4,750USD£3,689GBP
- Report
- February 2024
- 112 Pages
Africa, Middle East
From €4230EUR$4,750USD£3,689GBP
- Report
- February 2024
- 70 Pages
Asia Pacific
From €4230EUR$4,750USD£3,689GBP
- Report
- February 2024
- 80 Pages
Latin America
From €4230EUR$4,750USD£3,689GBP
- Report
- February 2024
- 90 Pages
Global
From €4230EUR$4,750USD£3,689GBP
- Report
- February 2024
- 90 Pages
Asia Pacific
From €4230EUR$4,750USD£3,689GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more